GLP-1

Sema is a synthetic long-acting glucagon-like peptide-1 (GLP-1) receptor agonist, structurally modified to resist enzymatic degradation and extend half-life. By mimicking native GLP-1 activity, it has become a widely studied compound in metabolic and endocrine research.

In preclinical and clinical studies, Sema has been shown to enhance glucose-dependent insulin secretion, slow gastric emptying, and reduce appetite through central satiety pathways. These effects contribute to improved glycemic control and reductions in body weight, making it a key research tool for investigating obesity, type 2 diabetes, and cardiometabolic disorders. Researchers often use it to explore incretin biology and its downstream impact on lipid metabolism, insulin sensitivity, and cardiovascular health.

All products are intended for in vitro or laboratory research use only. This compound is not intended for therapeutic or diagnostic purposes and has not been approved by the FDA for human or veterinary use.

** This product is in lyophilized powder form and requires reconstitution solution (BAC Water) for research.